• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book Apps
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » substance-abuse

Articles Tagged with ''substance-abuse''

Adolescent Marijuana Use and Clinical Practice

May 1, 2017
Timmen L. Cermak, MD
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Timmen L. Cermak, MD Private practice in psychiatry and addiction psychiatry in San Francisco and Marin County, CA; former president of the California Society of Addiction Medicine Dr. Cermak has disclosed that they have no relevant financial or other interests in any commercial companies pertaining to these educational activities.
There is conclusive evidence that marijuana use, particularly in early adolescence, can affect brain development. Most of the effect is on memory, attention, and executive function. How do we prevent these negative effects? Dr. Cermak's advice is: delay, delay, delay. The more success we have getting kids to delay onset of use, the more protection we provide.
Read More

The Neuroscience of Marijuana

May 1, 2017
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Daniel Carlat, MD Publisher, The Carlat Child Psychiatry Report Dr. Carlat has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
While the age-old tradition of smoking cannabis remains very common, several other options for preparing the drug are becoming widely available and frequently used. In this article, we’ll update you on the modern preparations and routes of administration.
Read More

From the Street to the Prescription Pad: Psychedelics Return to Psychiatry

March 1, 2017
Philip Wolfson, MD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Philip Wolfson, MD Director of The Center for Transformational Psychotherapy in San Anselmo, CA Dr. Wolfson has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
As marijuana has gained acceptance—it can now be prescribed to treat a wide variety of medical conditions in 28 states and Washington, DC—there has also been a shift in attitudes toward other mind-altering substances that, despite their reputation as drugs of abuse, show promise as therapeutic agents.
Read More

MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder

March 1, 2017
Shannon Clare Petitt, MA
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Shannon Clare Petitt, MA/ MDMA therapy training program manager at MAPS Public Benefit Corporation (MPBC), Santa Cruz, CA Ms. Petitt has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Ms. Petitt’s manages the program that selects and trains researchers for the MDMA-assisted psychotherapy protocols MAPS Public Benefit Corporation is conducting. The program has reviewed 300 applicants, and is in the midst of training 80 people who will work on therapy teams for Phase 3 trials. In addition to the training program, Ms. Petitt has also served as co-therapist on the MAPS-sponsored Phase 2 trial of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness.
Read More

A Kratom Update

January 1, 2017
Joshua Sonkiss, MD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Joshua Sonkiss, MD Editor-in-chief, The Carlat Addiction Treatment Report
If you have not yet heard of kratom (usually pronounced kray-tom or krah-tom), consider this an introduction. Kratom preparations are gaining popularity among substance users because of the plant’s opioid-like and stimulant properties.
Read More

Managing Drug-Seeking Patients

November 1, 2016
Damon Raskin, MD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Photo_Dr. Raskin_Q&A_sm Damon Raskin, MD Private practice internist in Pacific Palisades, California. Specializes in the treatment of addiction and substance abuse. Dr. Raskin has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Dr. Raskin discusses strategies when dealing with prescription-seeking patients, including common scenarios for helping clinicians decide whether a patient requesting opioids is endorsing more pain than they actually have.
Read More

Identifying and Deterring Drug Abuse and Diversion via PDMPs

November 1, 2016
Talia Puzantian, PharmD, BCPP
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Talia PuzantianTalia Puzantian, PharmD, BCPP Deputy Editor, The Carlat Psychiatry Report Dr. Puzantian has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
How do PDMPs work? To search for a patient in a PDMP, all you need to do is enter the person’s name and birthdate and click the search button. The PDMP will generate a patient activity report that will tell you what controlled substances the patient has picked up and where. The report gives you lots of detail, including the address of the patient; the drug names, doses, quantities, and refill information on any controlled substances that have been dispensed; and the applicable prescriber names, DEA numbers, pharmacy names, dispensing dates, and prescription numbers.
Read More

Tales from the History of Psychiatry: Opium, an Ancient Psychotropic

September 1, 2016
Marcia Zuckerman, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Marcia Zuckerman, MD Director of psychiatric services at Walden Behavioral Care in Waltham, MA Dr. Zuckerman has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
These days, opiates are primarily prescribed to treat pain. But there is a long history of using opiates to treat depression and other mental illness.
Read More

Evaluating and Treating Pain in Psychiatric Patients

September 1, 2016
Michael Robert Clark, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Expert QA Author PictureMichael Robert Clark, MD Associate professor & director of the Chronic Pain Treatment Program at The Johns Hopkins Hospital in Baltimore, MD Dr. Clark discloses that he has been a paid consultant to Collegium Pharmaceutical Inc. and Depomed, Inc. Dr. Carlat has reviewed this article and has found no evidence of bias in this educational activity.
Many chronic pain patients are dealing with psychiatric problems. Pain patients have tremendously high rates of major depressive disorder which is undertreated and underdiagnosed. It's easy to assume that the depression is a reaction to living with chronic pain, but in fact it’s often the other way around. Dr. Michael Robert Clark describes evaluations and treatment methods clinicians can use to address pain management with their patients.
Read More

Vilazodone Not Effective for Cannabis Dependence

September 1, 2016
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Bret A. Moore, PsyD, ABPP
Effective pharmacological treatments for cannabis dependence have eluded the field of addiction psychiatry. It’s not, however, due to a lack of trying. Theoretical connections between cannabinoids and the serotonin system have spurred a number of studies looking at the usefulness of SSRIs and buspirone.
Read More
Previous 1 2 3 4 5 6 7 8 9 10 11 12 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2637648401.jpg
    General Psychiatry

    Psychopharm Secrets: Coming Off Meds

    There’s a hidden placebo response to watch for when patients stop meds on their own.
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.